Royal Dutch Pharmacists Association
Impact in
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 28
- Pharmacology 43
- Pharmacogenetics and Drug Metabolism 25
- Drug-Induced Hepatotoxicity and Protection 7
- Top scholars
- Peter A. G. M. De SmetC. J. De BlaeyH. J. M. BeijerP. DesmetVera H.M. DeneerMarga NijenhuisJesse J. SwenRon H. N. van Schaik
- Journals
- European Journal of Human Genetics (13 papers)British Journal of Clinical Pharmacology (13 papers)Drug Safety (8 papers)Clinical Pharmacology & Therapeutics (8 papers)Frontiers in Pharmacology (7 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Royal Dutch Pharmacists Association
172 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 195
- Geriatrics and Gerontology 904
- Pharmacology 1.8k
- Family Practice 248
- Toxicology 300
- Complementary and alternative medicine 664
Countries citing scholars working at Royal Dutch Pharmacists Association
This map shows the geographic impact of research produced by authors working at Royal Dutch Pharmacists Association. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Royal Dutch Pharmacists Association with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Royal Dutch Pharmacists Association more than expected).
Fields of papers published by authors at Royal Dutch Pharmacists Association
This network shows the impact of papers affiliated with Royal Dutch Pharmacists Association at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Royal Dutch Pharmacists Association at the time of their publication.
About Royal Dutch Pharmacists Association
In recent decades, authors affiliated with Royal Dutch Pharmacists Association have published 240 papers, which have received a total of 7.2k indexed citations . Scholars at this organization have produced 28 papers in Geriatrics and Gerontology, 43 papers in Pharmacology, 8 papers in Family Practice, 40 papers in Pediatrics, Perinatology and Child Health and 17 papers in Complementary and alternative medicine on the topics of Pharmaceutical studies and practices (33 papers), Pharmaceutical Practices and Patient Outcomes (28 papers), Pharmacogenetics and Drug Metabolism (25 papers), Complementary and Alternative Medicine Studies (16 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Medication Adherence and Compliance (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Analytical Chemistry and Chromatography (7 papers). Their work is cited by papers focused on Geriatrics and Gerontology (904 citations), Pharmacology (1.8k citations), Family Practice (248 citations), Toxicology (300 citations) and Complementary and alternative medicine (664 citations). Authors at Royal Dutch Pharmacists Association collaborate with scholars in Netherlands, United States and United Kingdom and have published in prestigious journals including European Journal of Human Genetics, British Journal of Clinical Pharmacology, Drug Safety, Clinical Pharmacology & Therapeutics and Frontiers in Pharmacology. Some of Royal Dutch Pharmacists Association's most productive authors include Peter A. G. M. De Smet, C. J. De Blaey, H. J. M. Beijer, P. Desmet, Vera H.M. Deneer, Marga Nijenhuis, Jesse J. Swen, Ron H. N. van Schaik, Marcel L. Bouvy and Jan van der Weide.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.